当前位置: 首页 > 详情页

Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome

文献详情

资源类型:

收录情况: ◇ SCIE ◇ CSCD-C

机构: [1]Capital Med Univ, Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China; [2]Capital Med Univ, Anzhen Hosp, Dept Cardiol, 2 Anzhen Ave, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Non-ST elevation acute coronary syndrome Quality of life Therapeutic strategy

摘要:
Background Few studies have compared change in the health-related quality of life (HRQL) following treatment of non-ST-elevation acute coronary syndrome (NSTE-ACS) with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). This study is to compare changes in HRQL six months after hospital discharge between NSTE-ACS patients who underwent either PCI or CABG. Methods HRQL was assessed using the Seattle angina questionnaire at admission and six months after discharge in 1012 consecutive patients with NSTE-ACS. To assess associations of PCI and CABG with HRQL changes, logistic regression models were constructed treating changes in the score of each dimension of the Seattle angina questionnaire as dependent variables. Results Although both the PCI and CABG groups experienced angina relief and other improvements at 6-month follow-up (P < 0.001), the CABG relative to PCI group showed more significant improvements in angina frequency (P = 0.044) and quality of life (P = 0.028). In multivariable logistic analysis, CABG also was an independent predictor for both improvement of angina frequency (OR: 1.62, 95%CI: 1.09-4.63, P = 0.042) and quality of life (OR: 2.04, 95%CI: 1.26-6.92, P = 0.038) relative to PCI. Conclusions In patients with NSTE-ACS, both PCI and CABG provide great improvement in disease-specific health status at six months, with that of CABG being more prominent in terms of angina frequency and quality of life.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 老年医学
JCR分区:
出版当年[2012]版:
最新[2023]版:
Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Q3 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Capital Med Univ, Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Anzhen Hosp, Dept Cardiol, Beijing 100029, Peoples R China; [2]Capital Med Univ, Anzhen Hosp, Dept Cardiol, 2 Anzhen Ave, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Role of Stromal Cell-Derived Factor-1 in Patients With Non-ST Elevation Acute Coronary Syndrome [2]Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention [3]A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China [4]A modified HEART risk score in chest pain patients with suspected non-ST-segment elevation acute coronary syndrome [5]Perioperative fondaparinux vs nadroparin in non-ST-elevation acute coronary syndrome patients receiving higher-dose unfractionated heparin during percutaneous coronary intervention [6]非ST段抬高型急性冠状动脉综合征患者行经皮冠状动脉介入术后大出血事件的发生率及预测因素和预后 [7]Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention [8]非ST段抬高型急性冠脉综合征合并高甘油三酯血症腰围表型的冠状动脉评分 [9]A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis [10]Influence of Red Blood Cell DistributionWidth on Long-term Prognosis of Percutaneous Coronary Intervention for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院